Site icon OncologyTube

Novel combinational therapies: Is the increased toxicity worth the possibility of increased benefit?

Chung-Han (Joe) Lee, MD/PhD Memorial Sloan Kettering Cancer Center discusses Novel combinational therapies: Is the increased toxicity worth the possibility of increased benefit? at the Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL September 22, 2018

Exit mobile version